BRD2 and neoplasm: Although the immunological changes in draining lymph nodes by NAT have been limited, as shown, some of the DC-SIGN (+) dendritic cells may migrate into draining lymph nodes, whereby they express Siglec, present tumor-derived antigens, and initiate the activation of tumor antigen-specific CD8 (+) T cells.